| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.28 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |